Dimerix Limited is a clinical-stage biopharmaceutical company developing innovative therapies for unmet medical needs, particularly in kidney and respiratory diseases.
Ticker code: ASX:DXB
Sector: Healthcare | Industry: Biotechnology | Website: https://dimerix.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $285,087,883 | $225,904,128 | 600185024 | 77.93 | $222,174,534 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 24 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $13,204,071 | $68,283,808 | $97,481 | 0.0 | -13129.9 | -516.4 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Negative | 4.7 | $343,441 | $754,881 | 0.13 | 0.5 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | 1999-09-24 | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $0.475 | -3.1 | 2.2 | -3.1 | -15.2 | 3.3 | 14.5 |
ASX:DXB Price Chart with Volume and 3EMA
ASX:DXB Short Positions
Click HERE to understand why the above moving averages have been chosen.